Table 2.
Reported cases of nongastric MALT lymphoma with monoclonal gammopathy.
| Author/year | Age/sex | Primary MALT lymphoma | Chronic disease | Dissemination | Serum Ig | CD5 | Genetic findings | Reference |
|---|---|---|---|---|---|---|---|---|
| Levine et al./1989 | 56/M | Eye | — | BM | IgMλ | − | T(11;18) | [16] |
| Ueda et al./1996 | 48/M | Liver | — | — | IgMκ | + | NA | [31] |
| Matsumoto et al./1996 | 74/F | Duodenum | — | — | IgAκ | − | NA | [32] |
| Nakata et al./1997 | 74/M | Eyes | — | — | IgMκ | − | NA | [33] |
| Mak et al./1998 | 62/M | Kidney | IgA NP | GI tract | IgMλ | − | NA | [34] |
| Sakai et al./2000 | 72 | Ileum and colon | ITP, AIH | − | IgGκ | − | NA | [35] |
| Valdez et al./2001 | 50/M | Nasopharynx | — | BM | IgMκ | − | NA | [9] |
| 40/M | Eye and lung | — | — | IgMκ | − | NA | ||
| 60/F | Salivary gland | Gougerot syndrome | BM | IgMκ | − | NA | ||
| 61/F | Lung | — | PE, skin, and pericardium | IgMκ | − | NA | ||
| 74/M | Eye and pharynx | — | — | IgM, IgAκ | − | NA | ||
| Nagakawa et al./2002 | 61/M | Lung | — | BM | IgM | NA | [36] | |
| Pachmann et al./2002 | 59/ | Salivary gland | — | BM, LN, kidneys, liver | IgGλ | − | NA | [37] |
| Stokes et al./2002 | 72/F | Kidney | MPGN | — | IgMκ | − | NA | [38] |
| Thieblemont et al./2002 | 60/F | Thyroid | Hashimoto | — | IgGκ | − | NA | [39] |
| Saito et al./2004 | 65/F | Small bowel | GN and ascariasis | Ascites | IgMκ | NA | T(11;18) | [40] |
| Takasaki et al./2005 | 84/M | Lung | — | BM and PE | IgM | − | T(11;18) | [41] |
| Dalle et al./2006 | 49/M | Skin | Schnitzler syndrome | BM | IgMκ | + | NA | [42] |
| Gomyo et al./2007 | 67/F | Pleura | — | — | IgM | − | T(14:18) | [43] |
| Schulze et al./2007 | 75/M | Lung | — | BM | IgMκ | − | T(11;18) | [44] |
| Ohno and Isoda/2008 | 77/M | Lung | — | BM and PB | IgMκ | − | T(11;18) | [27] |
| Murota et al./2009 | 73/F | Skin | Schnitzler syndrome | BM | IgMκ | − | NA | [45] |
| Mikolaenko and Listinsky/2009 | 75/F | Salivary gland | RA | BM and lung | IgMλ | + | NA | [46] |
| Peces et al./2010 | 77/M | Kidney | Barrett's esophagus | BM | IgMκ | − | NA | [47] |
| Mitchum et al./2010 | 46/M | Skin | — | BM | IgMκ | − | Bcl-2 | [48] |
| Ikuta et al./2010 | 54/F | Colon | — | — | IgMκ | − | NA | [49] |
| Kim et al./2011 | 66/M | Small bowel | — | BM | IgMλ | − | NA | [50] |
| Lacoste et al./2013 | 74/F | Skin | Angiomatosis | BM and PB | IgMκ | + | NA | [51] |
| Wu et al./2014 | 70/M | Lung | — | — | IgAκ | − | NA | [30] |
| Chi et al./2014 | 72/F | Kidney | CKD | BM and PB | IgMκ | − | NA | [52] |
NA: not available; NK: normal karyotype; PE: pleural effusion; BM: bone marrow; PB: peripheral blood; IgA NP: IgA nephropathy; ITP: idiopathic thrombocytopenic purpura; AIH:autoimmune hepatitis; MPGN: membranoproliferative glomerulonephritis; GN: glomerulonephritis; RA: rheumatoid arthritis; CKD: chronic kidney disease.